These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23587170)

  • 1. White matter pathology in progressive supranuclear palsy (PSP): a quantitative study of 8 cases.
    Armstrong RA
    Clin Neuropathol; 2013; 32(5):399-405. PubMed ID: 23587170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laminar distribution of the pathological changes in frontal and temporal cortex in 8 patients with progressive supranuclear palsy.
    Armstrong RA; Cairns NJ
    Clin Neuropathol; 2009; 28(5):350-7. PubMed ID: 19788050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial patterns of the tau pathology in progressive supranuclear palsy.
    Armstrong RA; Cairns NJ
    Neurol Sci; 2013 Mar; 34(3):337-44. PubMed ID: 22411688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal pathology in progressive supranuclear palsy (PSP): a quantitative study of 8 cases.
    Armstrong RA; Lantos PL; Cairns NJ
    Clin Neuropathol; 2009; 28(1):46-53. PubMed ID: 19216220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive supranuclear palsy (PSP): a quantitative study of the pathological changes in cortical and subcortical regions of eight cases.
    Armstrong RA; Lantos PL; Cairns NJ
    J Neural Transm (Vienna); 2007; 114(12):1569-77. PubMed ID: 17680229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topography of hemispheric white matter pathology in ten cases of neuronal intermediate filament inclusion disease.
    Armstrong RA
    Clin Neuropathol; 2018; 37(5):239-244. PubMed ID: 29956645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration.
    Piao YS; Hayashi S; Wakabayashi K; Kakita A; Aida I; Yamada M; Takahashi H
    Acta Neuropathol; 2002 May; 103(5):469-74. PubMed ID: 11935262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial topography of the neurofibrillary tangles in cortical and subcortical regions in progressive supranuclear palsy.
    Armstrong RA; Lantos PL; Cairns NJ
    Parkinsonism Relat Disord; 2007 Feb; 13(1):50-4. PubMed ID: 17046313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter pathology in sporadic frontotemporal lobar degeneration with TDP-43 proteinopathy.
    Armstrong RA
    Clin Neuropathol; 2017; 36 (2017)(2):66-72. PubMed ID: 28128723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Widespread argentophilic structures in progressive supranuclear palsy--an autopsy case report].
    Hanihara T; Kubota H; Amano N; Yamaoka K; Yagishita S
    No To Shinkei; 1994 May; 46(5):487-92. PubMed ID: 8060688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An autopsied case of progressive supranuclear palsy presenting with cerebellar ataxia and severe cerebellar involvement.
    Iwasaki Y; Mori K; Ito M; Tatsumi S; Mimuro M; Yoshida M
    Neuropathology; 2013 Oct; 33(5):561-7. PubMed ID: 23320789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative study of the pathological changes in white matter in multiple system atrophy.
    Armstrong RA; Cairns NJ; Lantos PL
    Neuropathology; 2007 Jun; 27(3):221-7. PubMed ID: 17645235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between histopathological features of progressive supranuclear palsy and disease duration.
    Josephs KA; Mandrekar JN; Dickson DW
    Parkinsonism Relat Disord; 2006 Mar; 12(2):109-12. PubMed ID: 16337422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
    Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy.
    Ito K; Arai K; Yoshiyama Y; Kashiwado K; Sakakibara Y; Hattori T
    Acta Neuropathol; 2008 Jun; 115(6):623-8. PubMed ID: 18427815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
    Halliday GM; Macdonald V; Henderson JM
    Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process.
    Togo T; Dickson DW
    Acta Neuropathol; 2002 Oct; 104(4):398-402. PubMed ID: 12200627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic neuronal loss in the basal forebrain and mesopontine tegmentum of progressive supranuclear palsy and corticobasal degeneration.
    Kasashima S; Oda Y
    Acta Neuropathol; 2003 Feb; 105(2):117-24. PubMed ID: 12536222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The thalamic changes in progressive supranuclear palsy].
    Amano N; Nagatomo H; Yokoi S; Yagishita S; Saitoh A; Mizutani T
    No To Shinkei; 1992 May; 44(5):421-8. PubMed ID: 1520562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.